Company intelligence / Profile preview

Revisto

San Antonio, Texas, United Statesrevisto.com ↗

Ownership: Private
Development stage: Commercial

Overview

Revisto offers an AI-driven platform that automates and streamlines the Medical, Legal, and Regulatory (MLR) review process for pharmaceutical marketing materials. Their solution reduces time to market, enhances compliance, lowers costs, and has already been adopted by at least one Top 5 pharmaceutical company. Early deployments have demonstrated significant cost savings—estimated at $15 million or more per brand annually—by expediting content reviews while maintaining regulatory standards[1][2][3].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Eli Lilly and Company (investor/early adopter)

Beyond the preview

Go deeper on Revisto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revisto.

Explore the full profile